SONMFinancial Services · Capital Markets

SONM Stock Forecast: DNA X, Inc. Price Predictions for 2026-2027

Last close, 14 Sept 2026
$3.07
−3.00% on the day

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 5 of 100 as at 14 Sept 2026 — in the weakest quartile.

Market cap
$4.6M
Ticker Nerd rank
5 / 100
Median analyst target
Analysts covering
0
Revenue$0.0−100.0% y/y
Operating income−$1.3M
Net income−$1.2M
Free cash flow−$2.1M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−5.4%
1M
−12.1%
YTD
−2.7%
1Y
−75.0%
From 52W high
−81.8%
From 52W low
+11.5%
$3
$17
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

SONM stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores DNA X, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Sept 2026
5 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size
96
Volatility
62
Momentum
27
Revisions
25
Growth
17
Accruals
8
Quality
3
Value
1
Issuance
1

Size (96): Smaller than most of the companies we track.

Issuance (1): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

SONM stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SONM, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15Oct 25Jan 26Apr 26Jul 26SONM

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

Recent analyst actionsNewest first
DateFirmActionRatingTarget
14 May 2020B. Riley FBRMaintainsBuy
14 May 2020B. Riley SecuritiesMaintainsBuy$7.00$3.00
31 Oct 2019OppenheimerDowngradePerform
11 Sept 2019B. RileyMaintainsBuy
11 Sept 2019B. Riley SecuritiesMaintainsBuy$18$7.00
18 July 2019B. Riley FBRInitiatesBuy
9 July 2019National SecuritiesUpgradeBuy
10 June 2019National SecuritiesInitiatesNeutral
4 June 2019OppenheimerInitiatesOutperform

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SONM appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

SONM vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Sept 2026, DNA X, Inc. returned −75.0% against +17.0% for the S&P 500, dividends included.

SONM vs S&P 500, last 12 monthsTotal return, rebased to 100
20406080100120140Oct 25Jan 26Apr 26Jul 26SONMS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

SONM analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Fundamentals

DNA X, Inc. (SONM) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
10.1×

Cheaper than 58% of US stocks

Price / sales
−0.4×

Cheaper than 99% of US stocks

Price / book
−3.4×

Cheaper than 96% of US stocks

EV / EBITDA
−1.7×

Cheaper than 71% of US stocks

Growth & margins
Revenue growth (YoY)
−100.0%

Higher than 1% of US stocks

Earnings growth (YoY)
−100.0%

Higher than 1% of US stocks

Gross margin
Operating margin
54.2%

Higher than 97% of US stocks

Net margin
0.0%

Higher than 30% of US stocks

Returns & dividend
Return on equity
307.1%

Higher than 99% of US stocks

Return on assets
−18.7%

Higher than 20% of US stocks

Dividend yield

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

DNA X, Inc. (SONM) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • DNA X, Inc. has a market value of $4.6M and an enterprise value of $6.1M.

  • Revenue in the twelve months to 30 June 2026: −$27.9M. The latest quarter shrank 100.0% year on year.

  • Net income over the same four quarters: −$8.5M, a 30.6% net margin.

  • Free cash flow in the twelve months to 30 June 2026: −$14.6M.

  • Shares outstanding: 1.5M.

  • Trailing P/E: 10.1×; forward P/E: 3.6× — the forward figure prices analyst consensus estimates, not reported earnings.

  • DNA X, Inc. employs 4 people −$7.0M of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 15 Sept 2026

Data provided by Twelve Data

Peers

SONM vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelCapital Markets
CompanyMarket capTKN rank
SONMDNA X, Inc.$4.6M
5
ABTSAbits Group, Inc.$4.6M
21
DPUTop KingWin Ltd.$5.3M
61
MEGLMagic Empire Global Ltd.$6.1M
69
NCPLNetcapital, Inc.$3.3M
26
IPSTIP Strategy Holdings, Inc.$2.4M
31
PWCMPowerCompute, Inc.$1.8M
19

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own DNA X, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest SONM news & analysis

DNA X, Inc. Reports Second Quarter 2026 Financial Results

GlobeNewsWire · 19 Aug 2026neutral

DNA X, Inc. reported its second quarter 2026 financial results. During the quarter, the company strengthened its balance sheet with $1.8 million in cash from new convertible debt, followed by an additional $5.0 million raised through the sale of preferred stock after the quarter ended.

Why it matters — A SONM watcher would care because the new capital raises indicate measures to strengthen the company's balance sheet and support its operations.

FAQ

Frequently asked questions about SONM stock

How does Ticker Nerd's model rank SONM?

As at 14 Sept 2026, DNA X, Inc. ranks 5 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (96 of 100).

What is the SONM stock forecast for 2030?

No analyst covering DNA X, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SONM are extrapolating price history, which says nothing about the business.

How has SONM stock performed over the past year?

DNA X, Inc. returned -75.0% over the 12 months to 14 Sept 2026, with dividends reinvested. Past performance does not indicate future returns.

What does DNA X, Inc. do?

DNA X, Inc. is a digital asset management company focused on cryptocurrency trading services.

What is the latest news on SONM?

The most recent item we track (GlobeNewsWire, 19 Aug 2026): "DNA X, Inc. Reports Second Quarter 2026 Financial Results". DNA X, Inc. reported its second quarter 2026 financial results. During the quarter, the company strengthened its balance sheet with $1.8 million in cash from new convertible debt, followed by an additional $5.0 million raised through the sale of preferred stock after the quarter ended.

Company

About DNA X, Inc.

DNA X, Inc. is a digital asset management company focused on cryptocurrency trading services. The company operates an online platform that allows users to buy, sell, swap, and manage cryptocurrencies, with tools for automated trading strategies and recurring or limit-order execution. Its service offering is aimed primarily at individual crypto traders and is designed to support trading activity across digital assets and cash-equivalent currencies. DNA X, Inc. also emphasizes internet-based access and platform-driven engagement, with marketing supported by social media and word-of-mouth channels. Headquartered in San Diego, California, DNA X, Inc. represents a specialized participant in the broader digital assets market, serving users who seek direct access to crypto trading functionality through a dedicated online platform.

CEO Mr. Michael C. Mulica · 4 employees · United States · https://ir.dna-x.global